Background: Some single nucleotide polymorphisms (SNPs) in the cytochrome P450 gene lead to decreased enzyme activity and have an impact on drug metabolism. The present study was designed to investigate the patterns of genetic distinction across a hypervariable region of the gene, known to contain important SNPs, i.e.
View Article and Find Full Text PDFInterindividual differences in cytochrome P450 ( 2C19 activity may result in variations in the therapeutic response to drugs metabolized by this enzyme. Differences at gene level may translate into protein level with consequent impairment of the enzyme activity. As a result patients with such genetic differences might experience undesirable effects or no effect at all.
View Article and Find Full Text PDF